Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Lonnie Moulder
AddedMar 31, 2024
UpdatedMay 31, 2026
Lonnie Moulder

Lonnie Moulder

Founder, Tellus BioVentures

Crunchbase

Lonnie Moulder's Career

Tellus BioVentures
Tellus BioVentures

Florida, NY, US

Founder
Trevena
Trevena

King of Prussia, PA, US

Board Member· Board
Interius BioTherapeutics
Interius BioTherapeutics

Philadelphia, PA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Lonnie Moulder's Career

Tellus BioVentures
Tellus BioVentures
Investment FirmInvestment Firm42019Florida, NY, US
Founder
Trevena
Trevena
Public$546.6M352007King of Prussia, PA, US
Board Member· Board

Leadership at Trevena

Jake NunnJake NunnBoard Member
Robert LefkowitzRobert LefkowitzCo-Founder
Howard RockmanHoward RockmanBoard Member
Scott BraunsteinScott BraunsteinBoard Member
Carrie L. BourdowCarrie L. BourdowBoard Member
Mark H N CorriganMark H N CorriganBoard Member

Similar to Trevena

Tremeau PharmaceuticalsTremeau PharmaceuticalsConcord, MA, USPain Therapiesest. 2016Tremeau PharmaceuticalsConcord, MA, US · est. 2016

Massachusetts-based pharmaceutical company specializing in non-opioid pain therapies.

Private Equity · $115.2M11
TrigeminaTrigeminaMoraga, CA, USPain Treatmentsest. 2006TrigeminaMoraga, CA, US · est. 2006

Trigemina, Inc.: A US-based pharmaceutical company innovating non-opiate pain therapies.

Series A · $27.6M11
Tris PharmaTris PharmaMonmouth Junction, NJ, USPharmaceuticalsest. 2000Tris PharmaMonmouth Junction, NJ, US · est. 2000

Tris Pharma, a New Jersey-based medical organization, innovates drug delivery technologies and medicines for disease treatment.

Public · $141.6M350
Neurana PharmaceuticalsNeurana PharmaceuticalsSan Diego, CA, USPharmaceuticalsest. 2013Neurana PharmaceuticalsSan Diego, CA, US · est. 2013

Neurana Pharmaceuticals: A US-based specialty pharma company innovating treatments for CNS diseases.

Series A · $60M5
Interius BioTherapeutics
Interius BioTherapeutics
Series B$103M602019Philadelphia, PA, US
Board Member· Board

Leadership at Interius BioTherapeutics

Phil JohnsonPhil JohnsonCEO
Saar GillSaar GillCo-Founder
Bruce PeacockBruce PeacockCo-Founder

Similar to Interius BioTherapeutics

Abintus BioAbintus BioSan Diego, CA, USGene Therapyest. 2020Abintus BioSan Diego, CA, US · est. 2020

Abintus Bio: Pioneering in vivo immune cell reprogramming and gene therapy for enhanced patient care.

Series B · $13.7M39
Intergalactic TherapeuticsIntergalactic TherapeuticsCambridge, MA, USGene Therapyest. 2020Intergalactic TherapeuticsCambridge, MA, US · est. 2020

Intergalactic Therapeutics: Pioneering the future of non-viral gene therapy for patients.

Series A · $75M41
Inceptor BioInceptor BioRaleigh, NC, USCell Therapyest. 2020Inceptor BioRaleigh, NC, US · est. 2020

Inceptor Bio: Advancing cell therapy solutions for hard-to-treat cancers through innovative partnerships.

Seed · $74.4M126
BlueWhale BioBlueWhale BioPhiladelphia, PA, USCell TherapiesBlueWhale BioPhiladelphia, PA, US

Philadelphia-based BlueWhale Bio accelerates cell-based therapies through innovative manufacturing.

Seed · $18M30

Lonnie Moulder's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · DunamuHyoung-nyon KimHyoung-nyon KimCo-Founder · Dunamu

People Similar to Lonnie Moulder

Ronald LindsayRonald LindsayBoard Member · Zebra BiologicsCamilla V. SimpsonCamilla V. SimpsonBoard Member · Spruce BiosciencesRyan ProtzkoRyan ProtzkoCo-Founder · ZestBioDave StewartDave StewartFounder & CEO · Zen EnterprisesPanos MoutafisPanos MoutafisBoard Member · ZenusRonald GoldRonald GoldBoard Member · NJ Bio